訊息原文

1 人回報1 則回應5 年前
Israel Revives COVID Restrictions As Cases Soar, Warns Of Possible Lockdown In September

BY TYLER DURDEN
TUESDAY, AUG 03, 2021 - 10:25 PM
Despite being the most heavily vaccinated country in the world, Israel has just imposed new restrictions on its population, and the body responsible for generating its COVID policies just admitted that a lockdown in September is no longer a remote possibility.
Israel's coronavirus cabinet announced Tuesday night that starting Aug. 20, the country will revive its full green pass system. Starting Sunday, masks will be mandatory in all indoor and outdoor gatherings and even fully vaccinated parents responsible for caring for a child in quarantine will be demanded to isolate as well (for children 12 and under).

Defense Minister Benny Gantz added: "We need to prepare the public and public opinion for a lockdown in September, which is a month in which the economic damage will be less, and accelerate the immunization effort to try to prevent it."
Also on Tuesday, Gantz announced that an additional 1K reservists will be called back to support the ministry’s activities related to the pandemic. Soldiers are employed for several logistical activities. And an additional 500 medics are going to be recruited to assist the Health Ministry’s vaccination efforts.
Less than a week has passed since the Israeli government announced it would start administering booster shots to people over age 60. And now that at least two European nations have said they're preparing to dole out booster shots, it's only a matter of time before Big Pharma gets its way in the US, leading to more sales for Pfizer and Moderna at newly inflated prices.

打了二劑還是要戴口罩 green pass 又如何?還得考慮封城!
第三劑?
昨夜風疏雨驟,試問疫中人 應是輝瑞肥荷包瘦!

現有回應

增加新回應

  • 撰寫回應
  • 使用相關回應 5
  • 搜尋

你可能也會對這些類似文章有興趣

  • 轉分享: 這是中研院生醫所所長郭沛恩院士 (他也是UCSF 教授)寫給前副總統陳健仁及時中部長,関於目前COVID-19 的一些建議,希望政府能夠接納。 Dear VP Chen, Hope that things are going well. I just completed my 9th quarantine after my 9th trip to Taipei during the pandemic and see that the Omicron variant of COVID-19 is now firmly established in Taiwan. While the CECC is moving quickly to address the widening spread of COVID-Omicron and is heading in the right direction, I find that the current policy is unsustainable and the messaging can be much improved. Since I was told that the CECC would welcome my suggestions, I have decided to do so. Please forward this message to the CECC for their consideration. 1. It is now very clear that COVID-Omicron is a very different disease than COVID-ALPHA/BETA/DELTA. Current vaccines are developed from COVID-ALPHA and cannot prevent INFECTION by COVID-Omicron even though they lower significantly the risk of SEVERE DISEASE and DEATH for those who are fully vaccinated and received booster shots recently. In addition, COVID-Omicron is highly contagious and has a very short incubation time; but it causes a milder disease, including shortened disease course and contagious period. 2. Because of the above, contact tracing does not work and avoiding infection is futile except one is in strict isolation or wears a PROPERLY FITTED N95 mask around others (see a very nice article about this in the NYT attached). This means that COVID testing in asymptomatic people is a waste of resources and is justified only in a limited set of situations (such as someone who works closely with vulnerable populations - e.g., nursing home and hospital workers - who has been in close contact with a positive case and needs to test negative to return to work). 3. Although the rate of hospitalization and death due to COVID-Omicron is low, when large populations are infected, the number of severe cases and severe disease is still significant (0.4% of 23 million people hospitalized = 92,000 in the hospital; 0.04% of 23 million people can die = 9,200 deaths) so the key is to keep the vulnerable people from developing severe disease. Medications used for COVID-ALPHA/BETA/DELTA variants such as antibody treatments and Remdesivir, etc., do not work for COVID-Omicron but the oral antivirals from Pfizer and Merck work amazingly well for preventing death (>85% reduction) and hospitalization. Paxlovid has done better in clinical trials to prevent hospitalization but it has many drug-drug interactions so many elderly people cannot use it. Molnupiravir has the theoretical risk of mutagenesis in pregnant women but for the elderly who are past reproductive age, it is a very safe and effective drug to use. I encourage the CECC to contact their counterparts in Japan, Singapore, Israel and the UK to get their experience in using these two oral anti-virals in the recent COVID-Omicron surge. [Full Disclosure: Dr. Dean Li, President of Merck Research Laboratories, is my brother-in-law so I am not pushing the Merck pill for obvious conflict of interest reasons.] Based on the above, my suggestions on messaging are: 1. Tell the country that COVID-Omicron is an entirely different disease than the previous COVID variants so the whole country IS NOT IMMUNE to getting the infection. However, through the sacrifice and cooperation of everyone in Taiwan, the country succeeded in preventing disease and death during the previous waves of infection that caused a lot of problems around the world. This is shared success that the CECC and everyone in Taiwan should take credit, be proud of, and very relieved by. 2. Despite the fact that no one is protected from infection, but because COVID-Omicron is mild, public health policy needs to be adjusted to focus on treating the vulnerable rather than preventing infection of all. 3. Acknowledge that some segments of society have been severely affected by COVID policies so the recovery of these sectors is taken in consideration in updating the public health policy. 4. Acknowledge that some COVID policies were confusing to the public in the past so the new policies will be more consistent and logical. For example, the policy of requiring masking outdoors while people eating at restaurants indoors are not required to mask makes no sense. My suggestions for the new policy are geared towards lowering hospitalization and death rates while avoiding unnecessary disruptions in people's lives: 1. Push vaccination for vulnerable groups (the elderly and those with pre-existing conditions that make them more prone to severe disease). Send vaccination nurses to the nursing homes and neighborhoods with elderly people to get everyone fully vaccinated (including booster shots). Getting the 30% of those 65-75 and 44% of elderly >75 who have not been fully vaccinated and boosted should be a high priority 2. Use the "test positive and treat" strategy for those in vulnerable groups. As I mentioned before, Paxlovid for all but Molnupiravir for those who cannot take Paxlovid. Treat them before their symptoms get worse because it is cheaper to give them the medicine than risk their need for hospitalization. 3. No more putting those with mild disease in special facilities or hospitals so that there are plenty of capacity for those who need hospitalization. 4. Recommend (not mandate with threat of punishment) those who have close contact with COVID-Omicron patients to mask around others for 5 days (no need to do so with household members because they are already given it to them) if they are asymptomatic. 5. No testing of asymptomatic people unless their job requires it (nursing home, hospital, etc.). 6. No more closing schools, factories, or offices because of positive COVID-Omicron cases. 7. No more mandatory masking except for those described in #4 above. People here are so used to masking that many will still do so with the threat of punishment. 8. No more mandatory quarantine, even for those who test positive. Highly recommend those who test positive to wear a mask when around people and not eat with others but not make it a punishable offense. [Treat them like people who have a bad flu, not like criminals.] 9. No more testing or quarantine requirements for visitors from abroad. As the local infection rate is now higher than that many other countries, there is no reason to require new arrivals to do anything different when they are asymptomatic. It's confusing to many that I can go anywhere in the world without quarantine but have to do quarantine plus multiple tests when arriving in Taiwan (and a handful of Asian countries). The benefit of the policies listed above is that the resources of the country are directed toward saving lives rather than collecting lots of infection data. It will reclaim the international travel hub status of Taoyuan International Airport (and not let Singapore and Seoul dominate the air travel sector) and revive the tourism, convention, airline, hotel businesses. It will simplify everyone's life and reduce anxiety. It may be counter intuitive but if you look at the data from the US university campuses and European countries, it is better to get as many young people infected as quickly as possible to shorten the surge while building up herd immunity for COVID-Omicron without a lot of severe cases. The old policy for flattening the curve is to prevent overwhelming the hospitals but with oral antivirals and milder disease, there is no need to flatten the curve. It is better to get the whole surge completed in 2 months like in most countries that pursue a more open policy. I am convinced that when the messaging is clear and based on current understanding of the situation, the people will embrace it and praise the CECC's leadership. Best, Pui -- Pui-Yan Kwok, MD, PhD Director, Institute of Biomedical Sciences Academia Sinica
    11 人回報1 則回應4 年前
  • Exactly, exactly. And the story behind the Intelligence League is a very simple one. After COVID ended up spreading around the United States and producing a gigantic domestic disaster, obviously, our intelligence services wanted to prove that they were not responsible for what happened, that they had provided the information to the top American leadership, which was just ignored. In other words, they wanted to get away from being blamed for the disaster. Therefore, four separate intelligence sources confirmed to ABC News that the secret report had been provided to the White House and our top leadership in November describing a potentially cataclysmic disease outbreak taking place in the city of Wuhan, China. The problem with it, the problem they ran into is then when somebody checked the timeline, they realized in November, there was no cataclysmic disease outbreak in Wuhan. At that point, according to all the available knowledge and retrospective evidence, probably a dozen or maybe 20 people were starting to feel a little bit sick in a city of 11 million. There was no way for any outside observer to possibly be aware of the disease outbreak at that point. In fact, the Chinese government itself only became aware of the outbreak at the end of December, six or seven weeks later. So naturally, the Pentagon immediately denied the existence of that report, said, you know, we don't care, four intelligence sources said that they produced the report, it never existed. However, a week later, Israeli television confirmed the existence of a report saying that report had been sent to Israel, it had been sent to all of our NATO allies in November, and it had been produced in the second week of November. Again, the second week of November was long before anybody in the world could have possibly been aware of the disease outbreak in Wuhan, except for the people responsible. It's fairly close to a smoking gun. It looks that way to me too. It's interesting, was it Esper they asked about this and he said, he said, I don't recall. Exactly. I mean, at that point, you know, again, it was an embarrassment that the report had been provided to these people and ignored until people realized that the dates proved that it was for knowledge of the outbreak in Wuhan. So in other words, it's one thing to have an embarrassment of the fact that the government ignored a report like that. It's another thing when the report proves who was responsible for the disease outbreak. And I mean, America, over the decades, America has spent $100 billion developing its bio warfare technology. America brought the Trump administration brought in Robert Cadillac, America's leading bio warfare expert in 2017. And in 2018, there was suddenly a mysterious viral epidemic that devastated China's poultry industry. In 2019, China's pig herds were annihilated. And then in late 2019, suddenly, the COVID epidemic brought up, which really raises all sorts of incredibly dark suspicions of what really happened. Do you think Trump's telling the truth that he wasn't in the loop? I definitely I don't doubt that the report might have been sent to Trump's desk. But I get the sense that Trump doesn't actually read a lot. And you have all these stories of, for example, Trump's senior officials hiding his own executive orders. He forgets about them. He would forget about them. And we were talking about administration that really was operating in a very strange way with the top figures in the administration running circles around the president ignoring the president. And I fully believe that Trump had absolutely no idea when COVID leaked back to the United States that it was an American bio warfare, bio warfare weapon that was coming to us. And that's the reason they ignored it. That's the reason his response was so lackadaisical. The perpetrators who actually were in the loop have somehow raised the alarm in such a way that the US could protect itself. Well, they did to some extent. I mean, for example, Robert Cadillac, again, our top bio warfare expert, from January to August 2019, Cadillac and his department ran something called the Crimson Contagion Exercise, in which federal and state officials in the United States planned out how they would ensure that if a mysterious virus, viral epidemic, mysterious respiratory virus suddenly appeared in China, that they would prevent it from devastating America and leaking back into China. Eight months they did it, and the virus of exactly that type suddenly appeared in China a couple of months after the end of that exercise. Now, as it turned out, the training obviously was insufficient. That's the understatement. It shows that the people involved in launching the attack against China.
    2 人回報1 則回應3 年前
  • Welcome to the Reuters.com BETA. Read our Editor's note on how we're helping professionals make smart decisions. June 30, 202110:11 AM CSTLast Updated 2 months ago Healthcare & Pharmaceuticals U.S. Commerce chief says Taiwan's TSMC asked for help getting COVID vaccines Reuters 3 minute read U.S. Secretary of Commerce Gina Raimondo takes a question during a press briefing at the White House in Washington, U.S., April 7, 2021. REUTERS/Kevin Lamarque/File Photo The logo of Taiwan Semiconductor Manufacturing Co (TSMC) is pictured at its headquarters, in Hsinchu, Taiwan, Jan. 19, 2021. REUTERS/Ann Wang/File Photo U.S. Secretary of Commerce Gina Raimondo takes a question during a press briefing at the White House in Washington, U.S., April 7, 2021. REUTERS/Kevin Lamarque/File Photo 1/2 The logo of Taiwan Semiconductor Manufacturing Co (TSMC) is pictured at its headquarters, in Hsinchu, Taiwan, Jan. 19, 2021. REUTERS/Ann Wang/File Photo WASHINGTON, June 29 (Reuters) - U.S. Commerce Secretary Gina Raimondo on Monday said she had spoken with the chief executive of Taiwan Semiconductor Manufacturing Co Ltd (2330.TW) (TSMC) and that he had asked for help getting access to COVID-19 vaccines. Raimondo told Reuters in an interview "he asked for help in that regard, he has spoken to high level officials in the White House. We have responded and we definitely want to be a good partner and I do think it's helping." Taiwan said two weeks ago it will allow officials from Taiwan's Foxconn and TSMC to negotiate on its behalf for COVID-19 vaccines. read more Mid-June the United States shipped 2.5 million COVID-19 vaccine doses to Taiwan, more than tripling Washington's previous allocation of shots for the island. read more TSMC said in a statement to Reuters that they believed "getting vaccines for Taiwan would help to protect the communities and ensure normal operations." Taiwan has been trying to speed up the arrival of the millions of vaccines it has on order as it deals with a rise in domestic cases, although infections remain comparatively low. The request from TSMC, the world's biggest manufacturer of semiconductors on contract, coincides with a global chip shortage that has slowed production of manufacturers around the world, including in the U.S. auto industry where it is forecast the crisis will hit the production of 3.9 million vehicles. Raimondo has a key role in resolving the crisis for U.S. companies. Although there has been no major impact so far on chip production in Taiwan since domestic cases began rising in the middle of May, some U.S. auto executives have told Reuters privately earlier this month they were concerned COVID-19 in Taiwan could impact the flow of semiconductors to U.S. factories. Reporting by David Shepardson in Washington; Additional reporting by Ben Blanchard in Taipei; Editing by Simon Cameron-Moore Our Standards: The Thomson Reuters Trust Principles. More from Reuters Credit Suisse to U.S. staff: get shot, or go home Credit Suisse to U.S. staff: get shot, or go home Credit Suisse to U.S. staff: get shot, or go home German business morale dips on new health worries German business morale dips on new health worries Xiaomi sees revenue surge, eyes EV-market debut Xiaomi sees revenue surge, eyes EV-market debut Toshiba reviewing new strategic ideas - sources Toshiba reviewing new strategic ideas - sources J&J says booster shot vastly increases antibdody J&J says booster shot vastly increases antibdody Qantas aims for international travel in December Qantas aims for international travel in December Air NZ suspends outlook as borders stay shut Air NZ suspends outlook as borders stay shut Japan suspends 1.6 mln doses of Moderna shot Japan suspends 1.6 mln doses of Moderna shot Shakes off menu at UK McDonald's as milk runs dry Shakes off menu at UK McDonald's as milk runs dry Legal Lookahead: Purdue Pharma makes final push to exit bankruptcy Legal Lookahead: Purdue Pharma makes final push to... Read Next United States Illinois Governor to order statewide mask mandate and order masks and vaccines for schools - media 7:55 PM CST Europe EU says COVID boosters may have higher legal risks without EMA approval 7:34 PM CST World Qatar offering COVID vaccines to Afghanistan evacuees yet to transit 7:29 PM CST Americas Brazil's Eurofarma to make Pfizer COVID-19 shots in Latin America 7:10 PM CST Sign up for our newsletter Subscribe for our daily curated newsletter to receive the latest exclusive Reuters coverage delivered to your inbox. Healthcare & Pharmaceuticals Healthcare & Pharmaceuticals · 8:04 PM CST Illinois governor to announce mask mandate, order vaccines for schools - reports Illinois Governor J.B. Pritzker is expected to announce a new COVID-19 policy for the state on Thursday, requiring eligible students and school staffers to be vaccinated and to wear masks in schools and colleges, the Chicago Tribune and other media reported. Healthcare & Pharmaceuticals EU says COVID boosters may have higher legal risks without EMA approval 7:34 PM CST Healthcare & Pharmaceuticals Japan suspends 1.6 mln doses of Moderna shot after contamination reports 8:05 PM CST Healthcare & Pharmaceuticals Sydney hospitals erect emergency tents as COVID-19 cases hit record 12:32 PM CST Healthcare & Pharmaceuticals New Zealand's Ardern says lockdown working to limit Delta spread 3:10 PM CST Latest Home Media Videos Pictures Graphics Browse World Business Legal Markets Breakingviews Technology Investigations Lifestyle About Reuters About Reuters Careers Reuters News Agency Brand Attribution Guidelines Reuters Leadership Reuters Fact Check Reuters Diversity Report Stay Informed Download the App Newsletters Information you can trust Reuters, the news and media division of Thomson Reuters, is the world’s largest multimedia news provider, reaching billions of people worldwide every day. Reuters provides business, financial, national and international news to professionals via desktop terminals, the world's media organizations, industry events and directly to consumers. Follow Us Thomson Reuters Products Westlaw Build the strongest argument relying on authoritative content, attorney-editor expertise, and industry defining technology. Onesource The most comprehensive solution to manage all your complex and ever-expanding tax and compliance needs. Checkpoint The industry leader for online information for tax, accounting and finance professionals. Refinitiv Products Eikon Information, analytics and exclusive news on financial markets - delivered in an intuitive desktop and mobile interface. Refinitiv Data Platform Access to real-time, reference, and non-real time data in the cloud to power your enterprise. World-Check Screen for heightened risk individual and entities globally to help uncover hidden risks in business relationships and human networks. Advertise With Us Advertising Guidelines Cookies Terms of Use Privacy Corrections Site Feedback All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays. © 2021 Reuters. All rights reserved
    4 人回報1 則回應5 年前
  • 以色列卫生部|辉瑞疫苗杀死的老年人比疾病本身杀死的老年人多40倍 2021年3月5日 摘要 以色列卫生部的最新分析得出结论,在最近5周的疫苗接种期间,辉瑞公司的新冠病毒疫苗导致的死亡人数”大约是该病毒本身导致死亡人数的40倍”,而年轻人的死亡人数则是病毒导致死亡人数的260倍。 以色列卫生部|辉瑞疫苗杀死的老年人比疾病本身杀死的老年人多40倍 New analysis from the Israeli Health Ministry concluded Pfizer's COVID vaccine killed"about 40 times more(elderly)people than the disease itself would have killed"during a recent five-week vaccination period,and 260 times more younger people than would have died from the virus. 以色列卫生部的最新分析得出结论,在最近5周的疫苗接种期间,辉瑞公司的新冠病毒疫苗导致的死亡人数"大约是该病毒本身导致死亡人数的40倍",而年轻人的死亡人数则是病毒导致死亡人数的260倍。 While in January a group of independent doctors concluded that experimental COVID-19 vaccines are"not safer"than the virus itself,a new analysis of vaccine-related death rates in Israel demonstrates that this may indeed be the case to dramatic levels. 今年1月,一组独立医生得出结论,实验性的2019冠状病毒疾病疫苗并不比病毒本身更安全,但对以色列与疫苗相关的死亡率进行的一项新分析表明,情况可能确实如此,达到了惊人的水平。 A re-analysis of published data from the Israeli Health Ministry by Dr.Hervé Seligmann,a member of the faculty of Medicine Emerging Infectious and Tropical Diseases at Aix-Marseille University,and engineer Haim Yativ reveal,in short,that the mRNA experimental vaccine from Pfizer killed"about 40 times more(elderly)people than the disease itself would have killed"during a recent five-week vaccination period.Among the younger class,these numbers are compounded to death rates at 260 times what the COVID-19 virus would have claimed in the given time frame. 艾克斯-马赛大学医学新兴传染病和热带疾病学院的 hervé Seligmann 博士和工程师 Haim Yativ 对以色列卫生部公布的数据进行了重新分析,简而言之,辉瑞公司的 mRNA 实验疫苗在最近五周的疫苗接种期间造成的死亡人数比疾病本身造成的死亡人数多40倍。在年轻一代中,这些数字加起来的死亡率是2019冠状病毒疾病病毒在给定时间范围内的死亡率的260倍。 While the full mathematical analysis may be found in the article itself,the authors demonstrate how among"those vaccinated and above 65,0.2%…died during the three-week period between doses,hence about 200 among 100,000 vaccinated.This is to be compared to the 4.91 dead among 100,000 dying from COVID-19 without vaccination." 虽然完整的数学分析可以在文章本身中找到,但是作者证明了"那些接种疫苗和超过65,0.2%的人......是如何在三周期间死亡的,因此在100,000接种疫苗的人中大约有200人。"。这个数字可以和没有接种疫苗的100,000名死于2019冠状病毒疾病中的4.91人相提并论 "This scary picture also extends to those below 65,"the researchers continued.During the five-week vaccination process"0.05%,meaning 50 among 100,000,died.This is to be compared to the 0.19 per 100,000 dying from COVID-19(who)are not vaccinated…Hence the death rate of this age group increased by 260(times)during this five-week period of the vaccination process,as compared to their natural COVID-19 death rate." 研究人员继续说:"这种可怕的情况也延伸到了65岁以下的人群。"在为期五周的疫苗接种过程中,"0.05%,即10万人中有50人死亡。因此,在这五周的疫苗接种过程中,这个年龄组的死亡率比他们的自然死亡率增加了260倍,而他们的自然死亡率为每100,000人中有0.19人,没有接种2019冠状病毒疾病......因此,这个年龄组的死亡率比他们的自然2019冠状病毒疾病死亡率增加了260倍 As reported by IsraelNationalNews(INN),Seligmann is of Israeli-Luxembourg nationality,has a biology degree from Hebrew University of Jerusalem,and has written more than 100 scientific publications.INN reports the researchers"have no conflicts or interests other than having children in Israel." 据以色列国家新闻报道,塞利格曼是以色列-卢森堡国籍,拥有希伯来大学的生物学学位,并发表过100多篇科学论文。国家旅游局报告说,研究人员"除了在以色列生孩子之外,没有其他利益冲突。" Yativ and Seligmann stipulate that even these"estimated numbers of deaths from the vaccine are probably much lower than actual numbers as it accounts only for those defined as COVID-19 deaths for that short time period and does not include AVC and cardiac(and other)events resulting from the inflammatory reactions." Yativ 和 Seligmann 规定,即使这些"估计的疫苗死亡人数也可能远远低于实际数字,因为它只包括那些在短时间内被定义为2019冠状病毒疾病死亡的人,而不包括由炎症反应导致的动静脉畸形和心脏(以及其他)事件。" Nor do these numbers"account for long-term complications,"they write. 他们写道,这些数字也不能"解释长期并发症"。 In addition,within several months they expect"mid-and long-term adverse effects of the vaccination as ADE(Antibody-dependent Enhancement)"begins to become manifest in those who have received the experimental Pfizer vaccine. 此外,在几个月内,他们预计"中期和长期的不良反应疫苗接种作为 ADE(抗体依赖性增强作用)"开始成为明显的那些已经接受实验辉瑞疫苗。 As explained by America's Frontline Doctors(AFLDS),ADE"is when anti-COVID antibodies,created by a vaccine,instead of protecting the person,cause a more severe or lethal disease when the person is later exposed to SARS-CoV-2 in the wild.The vaccine amplifies the infection rather than preventing damage." 正如美国前线医生(AFLDS)解释的那样,ADE"是指当人后来在野外暴露于 SARS-CoV-2时,由疫苗产生的抗Covid 抗体,而不是保护人体,导致更严重或致命的疾病。这种疫苗加重了感染,而不是防止了损害。" AFLDS provides an example of a vaccine produced to fight the Dengue fever,which resulted in deaths of 600 children in the Philippines due to ADE,and the filing of criminal charges against the decision-makers in 2019. 菲律宾儿童和青少年司提供了一个为防治登革热而生产疫苗的例子,登革热在菲律宾造成600名儿童死亡,2019年对决策者提出了刑事指控。 For these reasons and more,AFLDS and many other doctors strongly discourage the use of these experimental vaccines for most people while only acknowledging that it may be plausible for those over 70 years of age,yet acknowledging that such injections are"a higher risk than early or prophylactic treatment with established medications"(sources here, here, here, and here). 由于这些原因以及更多的原因,AFLDS 和许多其他医生强烈反对大多数人使用这些实验性疫苗,同时只承认这对70岁以上的人来说可能是合理的,但也承认这种注射"比早期或使用现有药物进行预防性治疗的风险更高"(来源是这里、这里、这里和这里)。 Given these death rates,Yativ and Seligmann also have harsh criticism for the severe pressure being imposed upon the population by Israeli authorities to receive these shots.According to INN,the researchers call these draconian efforts"a new Holocaust." 鉴于这些死亡率,Yativ 和 Seligmann 也受到严厉批评,因为以色列当局对居民施加了接受这些射击的严厉压力。国际犹太人学院称,研究人员将这些严酷的努力称为"新的大屠杀" In the past weeks,Israel's government made headlines when they adopted a"green pass"system,allowing people who have been injected to receive a green code,which then grants them entry into places such as entertainment and leisure facilities. 过去几周,以色列政府采用了"绿色通行证"制度,允许被注射者获得绿色代码,然后允许他们进入娱乐和休闲设施等场所。 As the country reopens after a two-month lockdown,the green pass would be given only to those who had been injected,not to people who tested negative for the virus.The proposed benefits include access to"non-essential"businesses as well as not being required to self-isolate if identified as a close contact of a confirmed case of COVID-19,and not having to self-isolate after a return from what the government calls a"red location." 随着这个国家在两个月的封锁后重新开放,绿色通行证将只发给那些被注射的人,而不是那些病毒检测呈阴性的人。拟议的好处包括可以进入"非必要"的企业,如果被确认为确诊的2019冠状病毒疾病病例的密切接触者,不必自我隔离,也不必在从政府所谓的"红色地点"返回后自我隔离 Despite there being no proof that these experimental vaccines actually prevent transmission of the virus,Israel's minister for health,Yuli Edelstein,said upon the release of the vaccine"passport"that"(g)etting vaccinated is a moral duty.It is part of our mutual responsibility."He went further,declaring,"Whoever does not get vaccinated will be left behind." 尽管没有证据表明这些实验性疫苗实际上能够阻止病毒的传播,但以色列卫生部长 Yuli Edelstein 在疫苗"护照"发放时表示,"(g)接种疫苗是一种道德义务。这是我们共同责任的一部分。"他更进一步,宣称:"不接种疫苗的人将被留下。" The green pass needs renewing every six months,and despite holding one,an individual must still abide by masking and physical distancing rules.The Jerusalem Post also reported that legislation is being considered to grant employers the right to refuse unvaccinated people entry into the workplace. 绿色通行证需要每六个月更新一次,尽管持有绿色通行证,个人仍然必须遵守伪装和物理距离规则。《耶路撒冷邮报》还报告说,正在考虑通过立法给予雇主拒绝未接种疫苗的人进入工作场所的权利。 Such measures prompted Business Insider to describe the country as"waging a war on the unvaccinated."Meanwhile,Dr.Anthony Fauci,chief medical adviser to President Joe Biden,has styled Israel's vaccination response as"extraordinarily good." 这些措施促使商业内幕组织将这个国家描述为"向未接种疫苗的人发动战争"与此同时,总统乔·拜登的首席医疗顾问安东尼·福奇博士将以色列的疫苗接种反应形容为"非常好" 来源: https://www.lifesitenews.com/news/experimental-vaccine-death-rate-for-israels-elderly-40-times-higher-than-covid-19-deaths-researchers
    5 人回報1 則回應5 年前
  • (-)(-)(-)(-)(-)(-)(-)(-)美國黑水公司與蔡政府聯合 拿台灣當人體實驗室 台灣人,你還要忍多久? (路透社2021-06-04 獨家報導 全文中英對照稿) (-)(-)(-)(-)(-)(-)(-)(-) (根據維基百科:路透社乃出生於德國的保羅路透(Paul Reuters)於1851年時在倫敦創辦,歷史悠久,旗下有2500名記者及600名攝影記者,從全球200多個社址發出報導,是全球最大、也是最有公信力的跨國媒體機構之一) (以下中英文逐段並列翻譯,6分鐘內可讀完, 英文連結列在最後) WASHINGTON, June 4 (Reuters) - Erik Prince, the founder of controversial private military firm Blackwater and a supporter of former President Donald Trump, jumped into the COVID-19 business late last year with a deal to distribute an experimental vaccine should it be approved, according to three people familiar with the arrangement and business records seen by Reuters. 路透社2021年6月4日華盛頓報導 — 普林斯(Erik Prince)是頗具爭議性的私人軍火公司「黑水」的創辦人,也是美國前總統川普的擁護者。根據路透社訪問過,熟悉黑水公司運作與交易紀錄的三位人士,普林斯從去年下半年起,也躍入新冠疫苗的商圈,企圖掌握一支目前尚在實驗階段的疫苗,以便未來若取得認證後,得以擁有銷售權。 The COVID-19 vaccine, known as UB-612, is being developed by a privately-held U.S. firm called COVAXX. 那支被稱為UB-612的新冠肺炎疫苗,乃是一家美國私人企業COVAXX所開發的。(譯者註:也就是聯亞生技所開發的聯亞疫苗) The company has said the vaccine shows promise in protecting people against coronavirus, based on a small study of 60 patients in Taiwan. It hasn't provided data on safety and efficacy from large clinical trials, information that is usually required before a vaccine is authorized for public use. 該公司宣稱已在台灣60位病人中進行過小型實驗,顯示該疫苗可望保護病人對抗新冠肺炎,但尚未提供任何大型臨床實驗所得到,關於安全性及效能方面的數據,而那通常是疫苗可被認證供民眾施打前的必要條件。 COVAXX is unrelated to the similar-sounding but better-known "COVAX," a global vaccine distribution program backed by the World Health Organization. 以上所提到的這支COVAXX 疫苗,與另一支國際衛生組織(WHO)早已認證,也較知名的COVAX疫苗,聽起來頗相像,但成分截然不同,請勿混淆。 Since the start of the pandemic in 2020, the COVAXX vaccine has attracted some big-name backers, including endorsements from entrepreneur Peter Diamandis, who co-founded the company, and motivational speaker Tony Robbins. In March, the company raised $1.35 billion in a private placement, according to U.S. securities filings. 從2020年新冠疫情逐漸升高開始,這支COVAXX 疫苗就吸引了一些重量級人士的支持,包含來自創業家彼得戴曼迪斯 (Peter Diamandis,該公司的共同創辦人)以及勵志演說家羅賓斯(Tony Robbins)的背書。根據他們三月向美國證券交易委員會所提交的文件,那時該公司已經私募了13.5億美金。 Prince's involvement in vaccine distribution, which has not been previously reported, sheds new light on the race to profit from the uncertainties of the pandemic. Vaccine supply deals have often been forged through direct government ties to drugmakers, global health organizations or diplomatic channels. 普林斯這段之前不為人知,爭取疫苗銷售權的行動,更讓人看清面對疫情,人心惶惶時,各方爭發疫苗財的真貌。疫苗供應方面的交易,往往取決於製藥廠、世界衛生組織或外交管道,是否能直接與政府打上交道。 Reuters couldn't determine how Prince first became associated with COVAXX, or whether he has brokered any vaccine supply deals. 路透社無法得知普林斯從何時開始與COVAXX掛鉤,或他是否曾經擔任任何疫苗供應交易的掮客。 Prince did not respond to questions for this story. A source close to Prince said that "Erik has been helping a vaccine manufacturer set up distribution," but declined to give details. 普林斯並未回應記者針對以上情節所提出的問題。一位接近普林斯的人士僅說「Erik(普林斯)已經在協助一家疫苗製造商設置銷售管道」但拒絕說明更多細節。 Diane Murphy, a public relations consultant for Vaxxinity Inc, which owns COVAXX, declined to answer questions related to Prince. In a statement to Reuters, she said that the company has "accepted introductions from a variety of private, public and non-profit intermediaries, both formally and informally." COVAXX 母公司Vaxxinity 公司的公關顧問墨菲(暫譯, Diane Murphy)拒絕回答與普林斯有關的提問。她只在對路透社發表的一張紙上聲明中說,該公司已經「正式或非正式地,與一些來自私人、政府或非營利機構的中間人有了初步的接觸。」 'DOLLARS PER DOSE' 每劑疫苗的佣金 Prince has made headlines for years, first as chief executive of Blackwater, whose security guards fatally shot more than a dozen Iraqi civilians in Baghdad in 2007. After he left Blackwater, Prince pushed to privatize the war in Afghanistan by having contractors fight instead of the U.S. military and became embroiled in an investigation into possible collusion between the Trump election campaign and the Russian government. 普林斯的名字多年來常上報紙頭版,首先是因為2007年他還身為黑水公司總裁時,他私人保鑣在巴格達射死了十多位伊拉克百姓。他離開黑水公司之後,又推動在阿富汗雇用傭兵,來代替美國軍人打仗,後來又捲入川普選舉時的通俄門。 Prince sought to recruit a close associate, the late Paul Behrends, a former Republican congressional staffer and lobbyist who represented Blackwater for over two years, to help in the COVAXX project. 普林斯本想招募已故的親密夥伴布倫茲(暫譯,Paul Behrends)協助COVAXX 計畫,因為布倫茲曾在共和黨眾議院中擔任幕僚,並為黑水公司遊說超過兩年。 In a series of text messages to Behrends, Prince described the potential for profit from selling the vaccines. 普林斯在一系列發給布倫茲的簡訊中,這樣形容銷售該疫苗可獲利的潛力: "There's room for a couple dollars per dose in commissions," Prince said in a Nov. 9 text to Behrends. He shared with Behrends a "Letter of Authorization" on COVAXX letterhead signed by senior vice president Brandon Schurter as proof of his distribution deal. Schurter did not respond to requests for comment. 普林斯在11月9日寫給布倫茲的簡訊中說:「每劑疫苗的佣金可達2美元」。普林斯還跟布倫茲分享了一封寫在COVAXX官方信箋,並由該公司資深副總舒特(暫譯,Brandon Schurter)簽字的「授權書」,證明他已獲得銷售權。針對以上事件,舒特本人並未回應路透社的提問。 The October 2020 letter said that an entity called Windward Capital, with an address in Abu Dhabi, was authorized to "assist in the process of creating distribution networks." Reuters could not find a Windward Capital registered in Abu Dhabi. But a company called Windward Holdings that handles "professional, scientific and technical activities" is listed there, with Erik Prince the sole named shareholder. 在該封寫於2020年10月的信中,普林斯宣稱已經在阿布扎比成立了一家名為「Windward 資產」的公司,被授權來「協助建立銷售網」。路透社無法在阿布扎比找到一間註冊為「Windward 資產」的公司,但找到了一間名為「Windward 控股」,目標在「處理專業方面、科學方面與技術方面活動」的公司,並且普林斯是該公司唯一掛名的股東。 Prince is also the managing member of a corporate entity called Windward Wyoming LLC, which says it has a "global distribution" deal with COVAXX, according to records of non-public business agreements seen by Reuters. The company was formed in October 2020, public incorporation records in Wyoming show. 普林斯同時也是一家名為「懷俄明州Windward 股份有限公司」的總經理。據路透社所見過,一份非公開的商業協定中說,該公司成立的目標為「在全球銷售COVAXX疫苗」。根據懷俄明州的官方資料,該公司成立於2020年10月。 Lawyers and other officials affiliated with the various Windward entities did not respond to requests for comment. 以上名為Windward的兩間公司,其律師及相關負責人都未回應路透社就以上所發出的提問。 Prince and Behrends were negotiating how to carve up prospective sales territories by country, said Barry Angeline, a friend of Behrends. But their possible collaboration was cut short in December, when Behrends died. 布倫茲的一位朋友安吉林(暫譯,Barry Angeline)說,普林斯和布倫茲曾經協商過,當如何針對不同國家的地區而提高疫苗的銷售量,但此合作之可能性因12月布倫茲過世而告吹。 Vaxxinity consultant Murphy told Reuters the company has a "focus on the developing market" – including the many countries that have been unable to acquire the shots made by global drugmakers and stockpiled by wealthier nations. Vaxxinity 的顧問墨菲告訴路透社,該公司「專注於開發中國家的市場」— 包含那些無法透過全球製藥廠得到疫苗,或被富有國家囤積,以致無法取得疫苗的國家。 HIGH-PROFILE BACKERS 聲名顯赫的支持者 COVAXX was formed in early 2020 as a subsidiary of United Biomedical Inc (UBI), a maker of diagnostic tests and veterinary vaccines, to address the coronavirus pandemic. In April, the company announced it was being consolidated into a new holding corporation called Vaxxinity. COVAXX的母公司United Biomedical Inc (UBI)公司,原本是製造檢驗試劑及動物疫苗的,於2020年初期分出子公司COVAXX,以對抗新冠疫情。四月時,該官司宣布被合併進入一家新的控股公司,名為Vaxxinity. COVAXX's backers were quick to publicize the vaccine's potential beginning in July, based on early tests in animals, and before the first clinical trials in people began in Taiwan. COVAXX的支持者從七月起,就已經開始大肆宣傳該疫苗的潛力,根據的不過是早期的動物實驗數據,甚至早在以台灣人首次進行臨床人體實驗之前。 Diamandis, who is listed as a co-founder of Vaxxinity, wrote in a July 30 post on his personal blog that the vaccine was safe for patients and likely effective in the elderly. He told Reuters he made it clear in those posts that his assertions were based on previous trial results of other vaccines developed by the company. 列名Vaxxinity共同創辦人的戴曼迪斯,2020年7月30日於自己私人部落格上宣稱,該疫苗不但可供病人安全接種,並且在年長者身上也有效。他告訴路透社說,他在部落格上清楚說明了,那些是根據自己公司「其他」疫苗「過去」實驗的結果而認定的。 A few weeks later, Robbins, the self-help coach, held a webinar promoting COVAXX titled "The most powerful vaccine you've never heard of." Robbins said in the video that he was one of the company owners. "I've invested in the company, so everyone knows. Because I've been blown away by seeing these results," he said. 幾週之後,有「自助教練」之稱的羅賓斯舉辦了一場網路論壇,來宣傳COVAXX,稱其為「你平生未見,最威力強大的疫苗」。羅賓斯在該影片中聲稱自己是該公司所有人之一,還說:「我要在這裡告訴大家,我投資這家公司,因為親眼目睹了施打這疫苗的神效。」 Robbins "remains an investor," his spokeswoman Jennifer Connelly said in a statement to Reuters. She added, "Mr. Robbins is not involved in the management or daily operations." 羅賓斯的女發言人康納莉(暫譯,Jennifer Connelly )在一篇給路透社的聲明中說「羅賓斯直到如今仍然是該公司的一位投資者,但他並未參與該公司日常的運作管理。」 In October, COVAXX and shipping giant Maersk announced a partnership to provide global transport of the vaccine as soon as it becomes available. The Maersk official quoted in the release, Rob Townley, said the company recognized the urgent need to safely deliver COVID-19 vaccines worldwide. COVAXX 和全球航運巨擘「快桅」公司於十月宣布合夥,將在疫苗上市後,以最快速度供應至全球。「快桅」公司的塔利(暫譯,Rob Townley)並在該聲明中說該公司認知到當務之急乃是將新冠疫苗安全運至全球各地。 Townley was briefly an aide to former U.S. Army general Michael Flynn during Flynn's short tenure as Trump's National Security Adviser. In an interview, Townley said he knows Prince but couldn't discuss Prince's involvement. 塔利曾經在川普總統任命佛林(Michael Flynn)擔任美國國家安全顧問的短短期間,短暫擔任過佛林的幕僚。塔利在一場訪問中說,他認識普林斯,但對普林斯所參與的事務不予置評。 Data on how well the vaccine works is still pending. In an email to Reuters, Vaxxinity’s Murphy said the company had completed the Phase 1 trial of 60 volunteers aged 20 to 55 in Taiwan, and is conducting a new study of 3,800 people there, including teens and elderly participants. The company plans larger trials in Brazil and India later this year. 該疫苗的果效尚有待數據證明。Vaxxinity 的墨菲在發給路透社的一封電子郵件中說,該公司已經結束在台灣針對60名,20-55歲志願者的第一期實驗。現在正在台灣進行為數3800人,包含青少年及年長者的新實驗。今年下半年計畫在巴西和印度展開更大規模的實驗。 Reporting by Aram Roston in Washington and Lisa Barrington in Abu Dhabi; Editing by Michele Gershberg 以上由在華盛頓的Aram Roston,以及在阿布札比的Lisa Barrington報導,由 Michele Gershberg編輯 以上路透社英文原稿連結為 EXCLUSIVE Blackwater founder Prince takes role in COVID vaccine venture | Reuters
    5 人回報1 則回應5 年前